tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
CPRX is currently covered by 5 analysts with an average price target of $28.69. This is a potential upside of $7.7 (36.68%) from yesterday's end of day stock price of $20.99.
Catalyst Pharmaceuticals's activity chart (see below) currently has 70 price targets and 78 ratings on display. The stock rating distribution of CPRX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 78.03% with an average time for these price targets to be met of 565 days.
Highest price target for CPRX is $34, Lowest price target is $29, average price target is $28.69.
Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 08-Nov-2024. First documented stock forecast 26-Apr-2016.
Currently out of the existing stock ratings of CPRX, 25 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$30
$9.4 (45.63%)
$30
13 days ago
(08-Nov-2024)
3/13 (23.08%)
$6.14 (25.73%)
215
Buy
$29
$8.4 (40.78%)
$29
5 months 15 days ago
(06-Jun-2024)
5/7 (71.43%)
$13.24 (84.01%)
930
Buy
$34
$13.4 (65.05%)
$27
8 months 20 days ago
(01-Mar-2024)
7/12 (58.33%)
$16.99 (99.88%)
782
Buy
$24
$6.99 (41.09%)
$22
1 years 5 months 1 days ago
(20-Jun-2023)
5/7 (71.43%)
$11.38 (90.17%)
408
Buy
$21
$0.4 (1.94%)
$20
1 years 9 months 14 days ago
(07-Feb-2023)
15/15 (100%)
$4.79 (29.55%)
370
What is CPRX (Catalyst Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on CPRX (Catalyst Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on CPRX (Catalyst Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on CPRX (Catalyst Pharmaceuticals)?
Which analyst is the currently most bullish on CPRX (Catalyst Pharmaceuticals)?
Which analyst is the currently most reserved on CPRX (Catalyst Pharmaceuticals)?
